GE 3.0T Signa HDx, GE Healthcare, Milwaukee, Wis.
Gadopentetate dimeglumine, Bayer Healthcare Pharmaceuticals, Wayne, NJ.
Bagley RS, Gavin PR, and Moore MP, et al. Clinical signs associated with brain tumors in dogs: 97 cases (1992–1997). J Am Vet Med Assoc 1999; 215:818–819.
Cherubini GB, Mantis P, and Martinez TA, et al. Utility of magnetic resonance imaging for distinguishing neoplastic from non-neoplastic brain lesions in dogs and cats. Vet Radiol Ultrasound 2005; 46:384–387.
Kraft SL, Gavin PR, and DeHaan C, et al. Retrospective review of 50 canine intracranial tumors evaluated by magnetic resonance imaging. J Vet Intern Med 1997; 11:218–225.
Lipsitz D, Higgins RJ, and Kortz GD, et al. Glioblastoma multiforme: clinical findings, magnetic resonance imaging, and pathology in five dogs. Vet Pathol 2003; 40:659–669.
Snyder JM, Shofer FS, and Van Winkle TJ, et al. Canine intracranial primary neoplasia: 173 cases (1986–2003). J Vet Intern Med 2006; 20:669–675.
Sturges BK, Dickinson PJ, and Bollen AW, et al. Magnetic resonance imaging and histological classification of intracranial meningiomas in 112 dogs. J Vet Intern Med 2008; 22:586–595.
Thomas WB, Wheeler SJ, and Kramer R, et al. Magnetic resonance imaging features of primary brain tumors in dogs. Vet Radiol Ultrasound 1996; 37:20–27.
Westworth DR, Dickinson PJ, and Vernau W, et al. Choroid plexus tumors in 56 dogs (1985–2007). J Vet Intern Med 2008; 22:1157–1165.